A Japanese scientist has developed a treatment targeting chronic kidney disease (CKD) in cats, potentially extending their lifespan to 30 years.⁠ ⁠ In 2015, Dr. Toru Miyazaki, an immunology specialist at the University of Tokyo, discovered a protein called apoptosis inhibitor of macrophage (AIM) that helps the kidneys flush out toxins using immunoglobin antibodies. Fueled by his passion for cats, Miyazaki has dedicated years of research to developing the “AIM” injection, a treatment targeting the root cause of feline kidney disease.⁠ ⁠ ⁠ 🐈️You can read more about the treatment in the full article on our website in our linkinbio ⁠ ⁠ ⁠ 💬Comment “email” to sign up to our daily newsletter.⁠ ⁠ 📰Follow us for the latest Asian News NextShark⁠ ⁠ ⁠ ⁠ ⁠ #news #cats #newtreatment #japan #chronickidneydisease #CKD #AIM #universityoftokyo #felinekidneydisease